Clinical Trials Directory

Trials / Completed

CompletedNCT00160719

HLA Sensitization Following Major Cortical Allograft Bone Procedures

Status
Completed
Phase
Study type
Observational
Enrollment
10 (actual)
Sponsor
University of Florida · Academic / Other
Sex
All
Age
12 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to find out whether or not antibodies to the donor bone are present in the blood of patients who receive the donor bone.

Detailed description

Patients who have bone cancer often have the cancerous bone removed by surgery and replaced with a piece of bone taken from a donor (a person who donates parts of their body to be used for transplants after their death). However, sometimes this replacement bone does not heal together with the patient's bone. The reason the bone does not heal is not known but it is thought that the patient's body may react to the donor bone by producing antibodies against cells on the donor bone. The purpose of this study is to find out whether or not antibodies to the donor bone are present in the blood of patients who receive the donor bone. You have been asked to participate in this study because you are scheduled to undergo this type of surgery.

Conditions

Interventions

TypeNameDescription
PROCEDUREretrieve blood samplesblood samples obtain pre-op, 6 and 12 months post-op

Timeline

Start date
1999-09-01
Primary completion
2010-03-01
Completion
2010-03-01
First posted
2005-09-12
Last updated
2012-10-30

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00160719. Inclusion in this directory is not an endorsement.